Status of fungal sepsis among preterm infants in 25 neonatal intensive care units of tertiary hospitals in China

Objective: To analyze the prevalence and the risk factors of fungal sepsis in 25 neonatal intensive care units (NICU) among preterm infants in China, and to provide a basis for preventive strategies of fungal sepsis. Methods: This was a second-analysis of the data from the "reduction of infecti...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 61(2023), 1 vom: 02. Jan., Seite 29-35
1. Verfasser: Cao, X C (VerfasserIn)
Weitere Verfasser: Jiang, S Y, Li, S J, Han, J Y, Zhou, Q, Li, M M, Bai, R M, Xia, S W, Yang, Z M, Ge, J F, Zhang, B Q, Yang, C Z, Yuan, J, Pan, D D, Shi, J Y, Hu, X F, Lin, Z L, Wang, Y, Zeng, L C, Zhu, Y P, Wei, Q F, Guo, Y, Chen, L, Liu, C Q, Li, X Y, Sun, H Q, Qi, Y J, Hei, M Y, Cao, Y
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:English Abstract Journal Article
LEADER 01000naa a22002652 4500
001 NLM351054227
003 DE-627
005 20231226050416.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.cn112140-20220918-00813  |2 doi 
028 5 2 |a pubmed24n1170.xml 
035 |a (DE-627)NLM351054227 
035 |a (NLM)36594118 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Cao, X C  |e verfasserin  |4 aut 
245 1 0 |a Status of fungal sepsis among preterm infants in 25 neonatal intensive care units of tertiary hospitals in China 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 04.01.2023 
500 |a Date Revised 11.01.2023 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To analyze the prevalence and the risk factors of fungal sepsis in 25 neonatal intensive care units (NICU) among preterm infants in China, and to provide a basis for preventive strategies of fungal sepsis. Methods: This was a second-analysis of the data from the "reduction of infection in neonatal intensive care units using the evidence-based practice for improving quality" study. The current status of fungal sepsis of the 24 731 preterm infants with the gestational age of <34+0 weeks, who were admitted to 25 participating NICU within 7 days of birth between May 2015 and April 2018 were retrospectively analyzed. These preterm infants were divided into the fungal sepsis group and the without fungal sepsis group according to whether they developed fungal sepsis to analyze the incidences and the microbiology of fungal sepsis. Chi-square test was used to compare the incidences of fungal sepsis in preterm infants with different gestational ages and birth weights and in different NICU. Multivariate Logistic regression analysis was used to study the outcomes of preterm infants with fungal sepsis, which were further compared with those of preterm infants without fungal sepsis. The 144 preterm infants in the fungal sepsis group were matched with 288 preterm infants in the non-fungal sepsis group by propensity score-matched method. Univariate and multivariate Logistic regression analysis were used to analyze the risk factors of fungal sepsis. Results: In all, 166 (0.7%) of the 24 731 preterm infants developed fungal sepsis, with the gestational age of (29.7±2.0) weeks and the birth weight of (1 300±293) g. The incidence of fungal sepsis increased with decreasing gestational age and birth weight (both P<0.001). The preterm infants with gestational age of <32 weeks accounted for 87.3% (145/166). The incidence of fungal sepsis was 1.0% (117/11 438) in very preterm infants and 2.0% (28/1 401) in extremely preterm infants, and was 1.3% (103/8 060) in very low birth weight infants and 1.7% (21/1 211) in extremely low birth weight infants, respectively. There was no fungal sepsis in 3 NICU, and the incidences in the other 22 NICU ranged from 0.7% (10/1 397) to 2.9% (21/724), with significant statistical difference (P<0.001). The pathogens were mainly Candida (150/166, 90.4%), including 59 cases of Candida albicans and 91 cases of non-Candida albicans, of which Candida parapsilosis was the most common (41 cases). Fungal sepsis was independently associated with increased risk of moderate to severe bronchopulmonary dysplasia (BPD) (adjusted OR 1.52, 95%CI 1.04-2.22, P=0.030) and severe retinopathy of prematurity (ROP) (adjusted OR 2.55, 95%CI 1.12-5.80, P=0.025). Previous broad spectrum antibiotics exposure (adjusted OR=2.50, 95%CI 1.50-4.17, P<0.001), prolonged use of central line (adjusted OR=1.05, 95%CI 1.03-1.08, P<0.001) and previous total parenteral nutrition (TPN) duration (adjusted OR=1.04, 95%CI 1.02-1.06, P<0.001) were all independently associated with increasing risk of fungal sepsis. Conclusions: Candida albicans and Candida parapsilosis are the main pathogens of fungal sepsis among preterm infants in Chinese NICU. Preterm infants with fungal sepsis are at increased risk of moderate to severe BPD and severe ROP. Previous broad spectrum antibiotics exposure, prolonged use of central line and prolonged duration of TPN will increase the risk of fungal sepsis. Ongoing initiatives are needed to reduce fungal sepsis based on these risk factors 
650 4 |a English Abstract 
650 4 |a Journal Article 
700 1 |a Jiang, S Y  |e verfasserin  |4 aut 
700 1 |a Li, S J  |e verfasserin  |4 aut 
700 1 |a Han, J Y  |e verfasserin  |4 aut 
700 1 |a Zhou, Q  |e verfasserin  |4 aut 
700 1 |a Li, M M  |e verfasserin  |4 aut 
700 1 |a Bai, R M  |e verfasserin  |4 aut 
700 1 |a Xia, S W  |e verfasserin  |4 aut 
700 1 |a Yang, Z M  |e verfasserin  |4 aut 
700 1 |a Ge, J F  |e verfasserin  |4 aut 
700 1 |a Zhang, B Q  |e verfasserin  |4 aut 
700 1 |a Yang, C Z  |e verfasserin  |4 aut 
700 1 |a Yuan, J  |e verfasserin  |4 aut 
700 1 |a Pan, D D  |e verfasserin  |4 aut 
700 1 |a Shi, J Y  |e verfasserin  |4 aut 
700 1 |a Hu, X F  |e verfasserin  |4 aut 
700 1 |a Lin, Z L  |e verfasserin  |4 aut 
700 1 |a Wang, Y  |e verfasserin  |4 aut 
700 1 |a Zeng, L C  |e verfasserin  |4 aut 
700 1 |a Zhu, Y P  |e verfasserin  |4 aut 
700 1 |a Wei, Q F  |e verfasserin  |4 aut 
700 1 |a Guo, Y  |e verfasserin  |4 aut 
700 1 |a Chen, L  |e verfasserin  |4 aut 
700 1 |a Liu, C Q  |e verfasserin  |4 aut 
700 1 |a Jiang, S Y  |e verfasserin  |4 aut 
700 1 |a Li, X Y  |e verfasserin  |4 aut 
700 1 |a Sun, H Q  |e verfasserin  |4 aut 
700 1 |a Qi, Y J  |e verfasserin  |4 aut 
700 1 |a Hei, M Y  |e verfasserin  |4 aut 
700 1 |a Cao, Y  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 61(2023), 1 vom: 02. Jan., Seite 29-35  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:61  |g year:2023  |g number:1  |g day:02  |g month:01  |g pages:29-35 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.cn112140-20220918-00813  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 61  |j 2023  |e 1  |b 02  |c 01  |h 29-35